PTC 081202

Your search result can be sorted in ascending/descending order by clicking on the column headings, with the exception of Review Status/Past Decision(s).
* Please click on the DIN/PIN hyperlink to look up for more details of any group coverage(s) which may apply to that particular drug product.

Products Found: 8

MFR

Review Status/
Past Decision(s)

02242971
AMIKACIN SULFATE
AMIKACIN SULFATE
250 MG / ML
INJ 
N/A
N/A
ML
NO

NOT A BENEFIT *

 

GENTAMICIN SULFATE
GENTAMICIN
40 MG / ML
INJ 
8.9447
N/A
ML
NO

REGULAR BENEFIT

 

TOBRAMYCIN
TOBI PODHALER
28 MG
INH  CAP
13.4510
N/A
CAP
NO

REGULAR BENEFIT

TOBRAMYCIN SULFATE
JAMP-TOBRAMYCIN
40 MG / ML
INJ 
2.7250
N/A
ML
NO

REGULAR BENEFIT

02230640
TOBRAMYCIN SULFATE
TOBRAMYCIN
40 MG / ML
INJ 
N/A
N/A
ML
NO

NOT A BENEFIT *

TOBRAMYCIN SULFATE
TEVA-TOBRAMYCIN
60 MG / ML
INH  SOL
5.4763
5.4763
ML
YES

REGULAR BENEFIT

TOBRAMYCIN SULFATE
TOBI
60 MG / ML
INH  SOL
10.7608
5.4763
ML
YES

REGULAR BENEFIT

 

TOBRAMYCIN SULFATE
TOBRAMYCIN
60 MG / ML
INH  SOL
5.4763
5.4763
ML
YES

REGULAR BENEFIT


To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.